The neuroendocrinology of chronic fatigue syndrome

AJ Cleare - Endocrine reviews, 2003 - academic.oup.com
Chronic fatigue syndrome (CFS) is a common and disabling problem; although most likely of
biopsychosocial origin, the nature of the pathophysiological components remains unclear …

The common link between functional somatic syndromes may be central sensitisation

JH Bourke, RM Langford, PD White - Journal of psychosomatic research, 2015 - Elsevier
Objectives Functional somatic syndromes are common and disabling conditions that all
include chronic pain, and which may be related to central nervous system sensitisation …

Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial

AJ Cleare, E Heap, GS Malhi, S Wessely, V O'Keane… - The Lancet, 1999 - thelancet.com
Background Reports of mild hypocortisolism in chronic fatigue syndrome led us to postulate
that low-dose hydrocortisone therapy may be an effective treatment. Methods In a …

The HPA axis and the genesis of chronic fatigue syndrome

AJ Cleare - Trends in Endocrinology & Metabolism, 2004 - cell.com
Many studies of patients with long-standing chronic fatigue syndrome (CFS) have found
alterations to the hypothalamo–pituitary–adrenal (HPA) axis, including mild hypocortisolism …

Eat, train, sleep—retreat? Hormonal interactions of intermittent fasting, exercise and circadian rhythm

S Haupt, ML Eckstein, A Wolf, RT Zimmer… - Biomolecules, 2021 - mdpi.com
The circadian rhythmicity of endogenous metabolic and hormonal processes is controlled by
a complex system of central and peripheral pacemakers, influenced by exogenous factors …

The neuroendocrinology of chronic fatigue syndrome and fibromyalgia

AJR Parker, S Wessely, AJ Cleare - Psychological medicine, 2001 - cambridge.org
Background. Disturbance of the HPA axis may be important in the pathophysiology of
chronic fatigue syndrome (CFS) and fibromyalgia. Symptoms may be due to:(1) low …

Free cortisol awakening responses are influenced by awakening time

I Federenko, S Wüst, DH Hellhammer… - …, 2004 - Elsevier
Psychobiological investigations on the hypothalamus–pituitary–adrenal (HPA) axis depend
on markers that adequately describe the activity of this system. There is evidence that the …

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial

R McKenzie, A O'Fallon, J Dale, M Demitrack… - Jama, 1998 - jamanetwork.com
Context.—Chronic fatigue syndrome (CFS) is associated with a dysregulated hypothalamic–
pituitary adrenal axis and hypocortisolemia. Objective.—To evaluate the efficacy and safety …

Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome

J Gaab, N Rohleder, V Heitz, V Engert, T Schad… - …, 2005 - Elsevier
OBJECTIVE: It has been suggested that a hypofunctional hypothalamic–pituitary–adrenal
(HPA) axis in chronic fatigue syndrome could result in an exaggerated release of pro …

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy

AJ Cleare, J Miell, E Heap, S Sookdeo… - The Journal of …, 2001 - academic.oup.com
These neuroendocrine studies were part of a series of studies testing the hypotheses that 1)
there may be reduced activity of the hypothalamic-pituitary-adrenal axis in chronic fatigue …